Pulmonary and central nervous system infiltration of chronic lymphocytic leukemia with concomitant diffuse large B-cell lymphoma: Case report and review of literature

Autores

  • Saulo F. D. Batista Medical Clinic Service, Pedro Ernesto University Hospital, Rio de Janeiro State University (UERJ). Rio de Janeiro, Brazil. https://orcid.org/0000-0001-8223-932X
  • Karina V. de Melo Hematology Service, Pedro Ernesto University Hospital, Rio de Janeiro State University (UERJ). Rio de Janeiro, Brazil.
  • Patricia Horn Hematology Service, Pedro Ernesto University Hospital, Rio de Janeiro State University (UERJ). Rio de Janeiro, Brazil.
  • Vinicius da C. Lisboa Department of General Pathology, Faculty of Medical Sciences. Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
  • Ana Sheila Cypriano Department of General Pathology, Faculty of Medical Sciences. Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
  • Andrea Pires Fonte Medicina Diagnóstica Laboratory. Niterói, Brazil.
  • Marilza de M. Ribeiro-Carvalho Department of General Pathology, Faculty of Medical Sciences. Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
  • Fábio Santiago Department of General Pathology, Faculty of Medical Sciences. Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil.
  • Maria Helena F. O. de Souza Department of General Pathology, Faculty of Medical Sciences. Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil. Postgraduate Program in Medical Sciences (PGCM), Rio de Janeiro State University (UERJ). Rio de Janeiro, Brazil.

DOI:

https://doi.org/10.12957/bjhbs.2020.59716

Palavras-chave:

Chronic lymphoid leukemia (CLL), Diffuse large B-cell lymphoma (DLBCL), Central Nervous System infiltration, Pulmonary infiltration.

Resumo

Introduction: Diffuse large B-cell lymphoma (DLBCL) and
chronic lymphoid leukemia (CLL) are lymphoproliferative
diseases of B lymphocytes. Objective: To describe the concomitance
of diseases with pulmonary and CNS involvement.
Clinical case: A 67-year-old patient with DLBCL and CLL
obtained partial remission of the diseases after six cycles of
standard combined chemotherapy. Relapse of CLL (del17p;
TP53+) occurred after 22 months, becoming refractory to a
new treatment. Monoclonal B lymphocyte infiltration was
found in the cerebrospinal fluid and bronchoalveolar lavage,
leading to death due to respiratory failure. Conclusion: The
unfavorable outcome shows a rare and serious complication
in the concomitance of these diseases.

Downloads

Não há dados estatísticos.

Referências

Chastain EC, Duncavage EJ. Clinical prognostic biomarkers

biomarkers in chronic lymphocytic leukemia and diffuse large

B-cell lymphoma.Arch Pathol Lab Med. 2015;139(5): 602–7.

Swerdlow SH, Campo E, Pileri SA, et al. Who Classification of

tumours of Haematopoietic and lymphoid Tissues. IARC, Lyon

Hallek M, Shanafelt TD, Eichhorst B. Chronic lymphocytic

leukaemia. Lancet. 2018;391(10129):1524–1537.

Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic

lymphocytic leukemia. Blood. 1975;46(2):219–234.

NCCN Clinical Practice Guidelines in Oncology. Chronic lymphocytic

leukemia/small lymphocytic lymphoma, version 4.2020.

National Comprehensive Cancer Network website. Nccn.org/

professionals/physician_gls/pdf/cll.pdf. Accessed April 22, 2020.

Ratterman M, Kruczek K, Sulo S, et al. Extramedullary chronic

lymphocytic leukemia: systematic analysis of cases reported

between 1975 and 2012. Leuk Res. 2014;(38):299–303.

Abuelgasim KA, Rehan H, Alsubaie M, et al. Coexistence of

chronic myeloid leukemia and diffuse large B-cell lymphoma

with antecedent chronic lymphocytic leukemia: a case report

and review of the literature. J Med Case Rep. 2018;(12):641.

Ornellas MHF, Fernandez TS, Diamond HR, et al. Cytogenetic

and immunophenotypic evidence of independent clonal origins

of concomitant chronic lymphocytic leukaemia and acute

myeloid leukaemia. European Journal of Haematology. 2001;

(66):281–283.

Langer S, Dass J, Mittal S, et al. Concomitant Presence of

CD5-Positive Diffuse Large B-Cell Lymphoma and Monoclonal

B Cells with the “CLL Immunophenotype” - Is It Richter’s Transformation?

Turk J Haematol. 2017;34(2):188–190.

Wei Q, Sebastian S, Papavassiliou P, et al. Metachronous/ concomitant

B-cell neoplasms with discordant light-chain or heavychain

isotype restrictions: evidence of distinct B-cell neoplasms

rather than clonal evolutions. Hum Pathol. 2014;(45):2063–

Anderson JR, Armitage JO, Weisenburger D. Epidemiology

of the non-Hodgkin’s lymphomas: Distributions of the major

subtypes differ by geographic locations. Annals of Oncology

;(9):717–72.

Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias

and leukostasis: a review of pathophysiology, clinical presentation

and management. Leuk Lymphoma. 2000;39(1-2):1–18.

Wąsik-Szczepanek E, Szymczyk A, Szczepanek D. et al.

Richter syndrome: rare complication of chronic lymphocytic

leukemia or small lymphocytic lymphoma. Adv Clin Exp Med.

;27(12):1683–1689.

Parikh AS, Shanafelt TD. Risk Factors for Richter Syndrome

in Chronic Lymphocytic Leukemia. Curr Hematol Malig Rep.

;(9):294–299.

Catherwood MA, Gonzalez D, Donaldson D, et al. Relevance

of TP53 for CLL diagnostics. J Clin Pathol. 2019;72(5):343–346.

Campo E, Cymbalista F, Ghia P, et al. TP53 aberrations

in chronic lymphocytic leukemia: an overview of the clini-

cal implications of improved diagnostics. Haematologica.

;103(12):1956–1968.

Strati P, Shanafelt TD. Monoclonal B-cell lymphocytosis and

early-stage chronic lymphocytic leukemia: diagnosis, natural

history, and risk stratification. Blood. 2015 Jul 23;126(4):454–

Strati P, Uhum HJ, Kaulfmann TJ, et al. Prevalence ad Characterisitics

Of Central Nervous System Involvement by Chronic

Lymphocytic Leukemia. Haematologica. 2016; 4.

Lopes da Silva R. Spectrum of neurologic complications in

chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk.

;(12):164–179.

Souza SL, Santiago F, Ribeiro-Carvalho M, et al. Leptomeningeal

involvement in B-cell chronic lymphocytic leukemia:

a case report and review of the literature. BMC Res Notes.

;(3)7:645.

Wanquet A, Birsen A, Choquet S, at al. Central Nervous System

Involvement in Chronic Lymphocytic Leukemia: Diagnosis and

Treatment in a Retrospective Cohort of Thirty Patients. American

Society of Hematology, 2015; 12(3).

Wanquet A, Birsen R, Lemal R, et al. Ibrutinib responsive

central nervous system involvement in chronic lymphocytic

leukemia. Blood. 2016 May 12;127(19):2356-8.

Barcos M, Lane W, Gomez GA, et al. An autopsy study of 1206

acute and chronic leukemias (1958 to 1982). Cancer. 1987 Aug

;60(4):827-37.

Downloads

Publicado

2021-05-07

Como Citar

1.
Batista SFD, de Melo KV, Horn P, Lisboa V da C, Cypriano AS, Pires A, et al. Pulmonary and central nervous system infiltration of chronic lymphocytic leukemia with concomitant diffuse large B-cell lymphoma: Case report and review of literature. BJHBS [Internet]. 7º de maio de 2021 [citado 2º de maio de 2025];19(2):124-9. Disponível em: https://www.e-publicacoes.uerj.br/bjhbs/article/view/59716

Edição

v. 19 n. 2 (2020)

Seção

Revisão de Literatura

Licença

Termo de transferência de direitos autorais/conflitos de interesses: após o aceite final do artigo para publicação, os autores deverão enviar o termo de transferência dos direitos assinados pelo autor principal representando cada um dos autores. Neste termo deverão ser declarados quaisquer conflitos de interesses.

Informação da autoria: o mérito da autoria científica deve ser limitado aos participantes que contribuíram intelectualmente no trabalho, além de uma colaboração efetiva para a realização da pesquisa. Portanto, para ser considerado um autor, cada colaborador deve, no mínimo, preencher as seguintes condições: (a) ter contribuído significativamente na concepção e desenho do estudo, ou na análise e interpretação dos dados; (b) ter contribuído substancialmente na elaboração do artigo, ou revisado criticamente o seu conteúdo intelectual e (c) ter aprovado sua versão final a ser publicada. A supervisão/coordenação geral do grupo de pesquisa por si só não justifica a autoria. A contribuição somente na aquisição de verbas provenientes de fontes financiadoras ou na coleta de dados também não é suficiente para justificar autoria. A fim de garantir a transparência dessas informações, os autores são solicitados a incluir uma declaração a respeito da autoria, descrevendo o papel dos autores no estudo e na preparação do manuscrito.